“Bone Grafts and Substitutes Market Report is set to have rapid growth due to the factors, such as High awareness regarding the commercially available products, higher healthcare expenditure, and availability of advanced healthcare infrastructure at global, regional and national level, influencing the industry trends in each of the sub-segments from 2019 to 2029”, says Visiongain Report
04 September 2019
Visiongain has launched a new pharma report Bone Grafts and Substitutes Market Report: By Material Type (Natural, Synthetic), By Application Type (Spinal Fusion, Craniomaxillofacial, Long Bone), By Region, And Segment Forecasts
Bone Grafts and substitutes are broadly utilized in orthopedic medical procedures for various applications. Rising instances of orthopedic issues due to weakened bones is forecasted to have higher demand in the coming future, projected from 2019-2029.
According to the United Nations Department of Economic and Social Affairs, Population Division, the number of people over the age of 60 was 841 million in 2013 and is expected to reach 2 billion in 2050. Therefore, the number of orthopedic surgeries it should increase with an increasing geriatric population that is more prone to orthopedic disorders. Therefore, it is expected that the market will see significant demand during the forecast period.
However, the risk of disease transmission and the immune response are the main factors that hinder market growth. Furthermore, the high cost of advanced products and the rigorous regulatory process involved further limit market development. Furthermore, the ethical issues associated with bone harvesting limit market growth in some regions.
The market is divided into global bone graft segments, replacing market reports based on material, application, and region.
Major applications include craniofacial, dentistry, feet and ankles, joint reconstruction, long bones, and spinal fixation. Improved reimbursement scope and the presence of a large elderly patient population are some of the factors that support market growth.
Leading companies featured in the report include: DePuy Synthes; Medtronic PLC; Nuvasive, Inc.; Orthofix Holdings, Inc.; Wright Medical Group N.V.; AlloSource, Inc.; and Stryker Corp.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.
21 July 2021
Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.
20 July 2021
Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.
14 July 2021
Digital innovation in clinical trials and renewed focus on home production will ensure a high growth market for supply chain optimisation.